H.R. 2276 (112th): To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.
Jun 22, 2011
112th Congress, 2011–2013
Died in a previous Congress
This bill was introduced on June 22, 2011, in a previous session of Congress, but was not enacted.
Debbie Wasserman Schultz
Representative for Florida's 20th congressional district
Read Text »
Last Updated: Jun 22, 2011
Length: 3 pages
About the bill
- Summary (CRS)
- 6/22/2011--Introduced.Directs the Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO) to: (1) study ways to provide independent, confirming genetic diagnostic test ...
Enacted — Signed by the President
Sep 16, 2011
- What is a bill?
The “H.R.” in “H.R. 2276” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 2276 — 112th Congress: To require the Director of the United States Patent and Trademark Office to conduct a .... Retrieved from https://www.govtrack.us/congress/bills/112/hr2276
“H.R. 2276 — 112th Congress: To require the Director of the United States Patent and Trademark Office to conduct a ....” www.GovTrack.us. 2011. April 21, 2015 <https://www.govtrack.us/congress/bills/112/hr2276>
|title=H.R. 2276 (112th)
|accessdate=April 21, 2015
|author=112th Congress (2011)
|date=June 22, 2011
|quote=To require the Director of the United States Patent and Trademark Office to conduct a ...